Clinical Trials Browser

Phase 1/2 × Myelodysplastic Syndromes × Darbepoetin alfa × Clear all

NCT00230321 2013-02-04

A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)

Phase 1/2 Completed

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Hematologic Neoplasms